Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

MGNXMGNX
Showing 8 of 25 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in MACROGENICS INC

Yes. Jacobs Levy Equity Management holds 1,002,274 shares of MGNX (Macrogenics), worth $4.6M, as of its Q2 2026 13F filing. It increased the position by 561,131 shares (+127.2%) from Q1 2026. Jacobs Levy Equity Management has held MGNX since Q4 2022, across 15 quarterly 13F filings.

Current Value

$4.6M

Current Shares

1M

Total Value Change

+$2.8M

Total Shares Change

+435,946

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+127.2%
$4.6M0.0%$4.62
43
2026-Q1
Decreased
441,143
-51.0%
$1.3M0.0%$2.89
0
2025-Q4
Increased
901,057
+10.4%
$1.5M0.0%$1.61
28
2025-Q3
Decreased
815,865
-18.8%
$1.4M0.0%$1.68
0
2025-Q2
Increased
1M
+51.0%
$1.2M0.0%$1.21
35
2025-Q1
Increased
665,351
+17.6%
$844,9960.0%$1.27
29
2024-Q4
Decreased
565,904
-0.1%
$1.8M0.0%$3.25
0
2024-Q3
Increased
566,328
+35.2%
$1.9M0.0%$3.29
33

Other major holders of MGNX: RA CAPITAL MANAGEMENT, L.P., WASATCH ADVISORS LP, Invesco Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used